Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 53

Related Articles by Review for PubMed (Select 19591631)

1.

The PEPvIII-KLH (CDX-110) vaccine in glioblastoma multiforme patients.

Heimberger AB, Sampson JH.

Expert Opin Biol Ther. 2009 Aug;9(8):1087-98. doi: 10.1517/14712590903124346. Review.

2.

Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma.

Sampson JH, Archer GE, Mitchell DA, Heimberger AB, Bigner DD.

Semin Immunol. 2008 Oct;20(5):267-75. doi: 10.1016/j.smim.2008.04.001. Epub 2008 Jun 9. Review.

3.

Targeting EGF receptor variant III: tumor-specific peptide vaccination for malignant gliomas.

Del Vecchio CA, Li G, Wong AJ.

Expert Rev Vaccines. 2012 Feb;11(2):133-44. doi: 10.1586/erv.11.177. Review.

PMID:
22309662
4.

Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme.

Swartz AM, Li QJ, Sampson JH.

Immunotherapy. 2014;6(6):679-90. doi: 10.2217/imt.14.21. Review.

5.

The epidermal growth factor variant III peptide vaccine for treatment of malignant gliomas.

Li G, Mitra S, Wong AJ.

Neurosurg Clin N Am. 2010 Jan;21(1):87-93. doi: 10.1016/j.nec.2009.08.004. Review.

PMID:
19944969
6.

EGFRvIII-targeted vaccination therapy of malignant glioma.

Choi BD, Archer GE, Mitchell DA, Heimberger AB, McLendon RE, Bigner DD, Sampson JH.

Brain Pathol. 2009 Oct;19(4):713-23. doi: 10.1111/j.1750-3639.2009.00318.x. Review.

7.

Targeting epidermal growth factor receptor variant III: a novel strategy for the therapy of malignant glioma.

Sonabend AM, Dana K, Lesniak MS.

Expert Rev Anticancer Ther. 2007 Dec;7(12 Suppl):S45-50. doi: 10.1586/14737140.7.12s.S45. Review.

PMID:
18076318
8.

The EGFRvIII variant in glioblastoma multiforme.

Gan HK, Kaye AH, Luwor RB.

J Clin Neurosci. 2009 Jun;16(6):748-54. doi: 10.1016/j.jocn.2008.12.005. Epub 2009 Mar 25. Review.

PMID:
19324552
9.

Topics in chemotherapy, molecular-targeted therapy, and immunotherapy for newly-diagnosed glioblastoma multiforme.

Okonogi N, Shirai K, Oike T, Murata K, Noda SE, Suzuki Y, Nakano T.

Anticancer Res. 2015 Mar;35(3):1229-35. Review.

PMID:
25750269
10.

Current vaccine trials in glioblastoma: a review.

Xu LW, Chow KK, Lim M, Li G.

J Immunol Res. 2014;2014:796856. doi: 10.1155/2014/796856. Epub 2014 Apr 3. Review.

11.

EGF receptor variant III as a target antigen for tumor immunotherapy.

Li G, Wong AJ.

Expert Rev Vaccines. 2008 Sep;7(7):977-85. doi: 10.1586/14760584.7.7.977. Review.

PMID:
18767947
12.

Enhancing dendritic cell-based vaccination for highly aggressive glioblastoma.

Batich KA, Swartz AM, Sampson JH.

Expert Opin Biol Ther. 2015 Jan;15(1):79-94. doi: 10.1517/14712598.2015.972361. Epub 2014 Oct 18. Review.

PMID:
25327832
13.

Perspectives for immunotherapy in glioblastoma treatment.

Finocchiaro G, Pellegatta S.

Curr Opin Oncol. 2014 Nov;26(6):608-14. doi: 10.1097/CCO.0000000000000135. Review.

PMID:
25210870
14.

Standards of care and novel approaches in the management of glioblastoma multiforme.

Hottinger AF, Stupp R, Homicsko K.

Chin J Cancer. 2014 Jan;33(1):32-9. doi: 10.5732/cjc.013.10207. Review.

15.

Dendritic cell-based vaccine for the treatment of malignant glioma: a systematic review.

Wang X, Zhao HY, Zhang FC, Sun Y, Xiong ZY, Jiang XB.

Cancer Invest. 2014 Nov;32(9):451-7. doi: 10.3109/07357907.2014.958234. Epub 2014 Sep 26. Review.

PMID:
25259676
16.

Cellular-based immunotherapies for patients with glioblastoma multiforme.

Xu X, Stockhammer F, Schmitt M.

Clin Dev Immunol. 2012;2012:764213. doi: 10.1155/2012/764213. Epub 2012 Feb 28. Review.

17.

Immunotherapy in human glioblastoma.

Szabo AT, Carpentier AF.

Rev Neurol (Paris). 2011 Oct;167(10):668-72. doi: 10.1016/j.neurol.2011.07.002. Epub 2011 Aug 31. Review.

PMID:
21885075
18.

Immunotherapy for glioma: getting closer to the clinical arena?

Finocchiaro G, Pellegatta S.

Curr Opin Neurol. 2011 Dec;24(6):641-7. doi: 10.1097/WCO.0b013e32834cbb17. Review.

PMID:
22027543
19.

Epidermal growth factor receptor as a therapeutic target in glioblastoma.

Kalman B, Szep E, Garzuly F, Post DE.

Neuromolecular Med. 2013 Jun;15(2):420-34. doi: 10.1007/s12017-013-8229-y. Epub 2013 Apr 11. Review.

PMID:
23575987
20.

Immunotherapy with tumor vaccines for the treatment of malignant gliomas.

Ajay D, Sanchez-Perez L, Choi BD, De Leon G, Sampson JH.

Curr Drug Discov Technol. 2012 Dec;9(4):237-55. Review.

PMID:
22339070
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk